Clinical research has found that Cognizin supports the health of mitochondria, the powerhouses within cells that actually produce the brain’s energy.* Healthy mitochondrial function results in higher levels of ATP—the body’s main energy storage molecule—in brain cells.
Discover the difference Cognizin® can make in your functional food and beverage products. Cognizin is a proprietary form ofciticoline, a potent brain-health nutrient clinically shown to support mental energy, focus, attention and recall.* Tested in human clinical trials and developed using a patented fermentation process, Cognizin is a pure, vegetarian, allergen-free,
GRAS ingredient that’s stable and effective.* For a functional difference consumers are sure to notice, add the proven brain power of Cognizin to your next product.
_ Provides the compound needed for the synthesis of phosphatidylcholine, a major constituent of brain tissue* 1, 2, 3, 4, 5
_ Enhances communication between neurons to support visual function* 6, 7
_ Helps protect neural structures from accumulating free-radical damage* 4
_ Supports brain performance by enhancing metabolism and healthy brain activity* 6,8,9
_ Assists in sustaining healthy mitochondria in the brain, the energy factories inside brain cells* 6, 8, 9
_ Supports healthy brain metabolism by nourishing and maintaining brain cell phospholipids* 3, 4, 5
_ Helps maintain normal levels of acetylcholine, a chemical that helps regulate memory and cognitive function* 6, 10
1. Wurtman RJ et al. Biochem Pharmacol. 2000; 60(7):989-92.
2. Rao AM et al. J Neurosci Res. 1999; 58(5):697-705.
3. Lopez-Coviella I et al. J Neurochem. 1995; 65(2):889-94.
4. Conant R, Schauss AG. Alt Med Rev. 2004; 9:1, 17-31.
5. Babb SM et al. Psychopharmacology (Berl). 2002; 161:248-54.
6. Fiorvanti M, Yanagi M. The Cochrane Library, Oxford, England. 2006: Issue 4.
7. Secades JJ, Lorenzo JL. Meth Find Exp Clin Pharmacol. 2006; 27 (Suppl B):1-56.
8. Watanabe S et al. Folia Psychiatr Neurol Jpn. 1975; 29(1):67-76.
9. Silveri MM et al. NMR Biomed. 2008; 21(10):1066-75.
10. Spiers PA et al. Arch Neurol. 1996; 53:441-48.
